CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-01 | Wang Xiaodong Director | Sale | −1,300 | $138.53 | $180K | 2,700 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −100 | $139.46 | $14K | 2,600 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −200 | $143.58 | $29K | 2,400 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −200 | $145.95 | $29K | 2,200 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −200 | $147.51 | $30K | 2,000 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −1,000 | $150.00 | $150K | 1,000 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −600 | $152.14 | $91K | 400 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −200 | $152.92 | $31K | 200 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −200 | $154.07 | $31K | 0 |
| 2019-03-01 | Wang Xiaodong Director | Sale | −1,000 | $150.00 | $150K | 0 |
| 2018-12-18 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion | +10,141 | $29.10 | $295K | 10,141 |
| 2018-12-18 | Peterson Amy C. CMO, Immuno-oncology | Sale | −1,631 | $131.74 | $215K | 8,510 |
| 2018-12-18 | Peterson Amy C. CMO, Immuno-oncology | Sale | −1,897 | $132.70 | $252K | 6,613 |
| 2018-12-18 | Peterson Amy C. CMO, Immuno-oncology | Sale | −2,402 | $133.88 | $322K | 4,211 |
| 2018-12-18 | Peterson Amy C. CMO, Immuno-oncology | Sale | −3,600 | $134.81 | $485K | 611 |
| 2018-12-18 | Peterson Amy C. CMO, Immuno-oncology | Sale | −611 | $135.54 | $83K | 0 |
| 2018-12-18 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion · Share Option (Right to Buy) | −131,833 | 820,000 | ||
| 2018-12-17 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion | +9,859 | $29.10 | $287K | 9,859 |
| 2018-12-17 | Peterson Amy C. CMO, Immuno-oncology | Sale | −900 | $130.37 | $117K | 8,959 |
| 2018-12-17 | Peterson Amy C. CMO, Immuno-oncology | Sale | −2,700 | $131.80 | $356K | 6,259 |
Page 105 of 123 · 2,455 trades